Beacon Falls, CT, United States of America

Aaron Timothy Karlak

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aaron Timothy Karlak. Retrieved from https://idiyas.com/inventor/aaron-timothy-karlak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aaron Timothy Karlak: Innovator in Anti-PD-1 Antibodies

Introduction

Aaron Timothy Karlak is a notable inventor based in Beacon Falls, CT (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic and diagnostic methods.

Latest Patents

Karlak holds a patent for Anti-PD-1 antibodies. This invention relates to new anti-PD-1 (Programmed cell death 1) antibodies and antigen-binding fragments thereof. These innovations are aimed at enhancing therapeutic and diagnostic methods and compositions using them. He has 1 patent to his name.

Career Highlights

Aaron Timothy Karlak is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work focuses on advancing medical treatments through innovative antibody research.

Collaborations

Some of his notable coworkers include David A. Blair and Nicole K. Garaffa. Their collaborative efforts contribute to the ongoing research and development in the field of biotechnology.

Conclusion

Aaron Timothy Karlak is a prominent figure in the biotechnology sector, recognized for his innovative work on anti-PD-1 antibodies. His contributions are paving the way for advancements in therapeutic and diagnostic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…